HSBC Holdings’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-48,162
Closed -$12M 3252
2022
Q3
$12M Sell
48,162
-6,657
-12% -$1.8M 0.02% 775
2022
Q2
$13.8M Buy
54,819
+9,071
+20% +$2.45M 0.02% 726
2022
Q1
$15.1M Sell
45,748
-12,470
-21% -$3.84M 0.02% 699
2021
Q4
$21M Sell
58,218
-71,397
-55% -$24.1M 0.02% 656
2021
Q3
$42.3M Buy
129,615
+7,347
+6% +$2.49M 0.04% 375
2021
Q2
$38.3M Buy
122,268
+81,022
+196% +$24.9M 0.04% 409
2021
Q1
$13M Buy
41,246
+3,013
+8% +$964K 0.02% 726
2020
Q4
$12.3M Buy
38,233
+13,287
+53% +$3.68M 0.02% 731
2020
Q3
$6.88M Buy
24,946
+3,088
+14% +$890K 0.01% 838
2020
Q2
$5.28M Sell
21,858
-5,204
-19% -$1.04M 0.01% 846
2020
Q1
$3.98M Sell
27,062
-2,751
-9% -$457K 0.01% 919
2019
Q4
$5.07M Buy
29,813
+4,132
+16% +$766K 0.01% 1094
2019
Q3
$4.57M Buy
25,681
+96
+0.4% +$20.8K 0.01% 1230
2019
Q2
$6.66M Sell
25,585
-2,230
-8% -$592K 0.01% 1028
2019
Q1
$7.94M Buy
27,815
+7,685
+38% +$2.55M 0.01% 918
2018
Q4
$6.54M Buy
20,130
+1,178
+6% +$409K 0.01% 1006
2018
Q3
$8.52M Sell
18,952
-9,703
-34% -$3.82M 0.01% 924
2018
Q2
$11.7M Buy
28,655
+24,784
+640% +$8.98M 0.02% 736
2018
Q1
$1.13M Buy
3,871
+2,167
+127% +$549K ﹤0.01% 1601
2017
Q4
$319K Buy
+1,704
New +$318K ﹤0.01% 1682

Other funds holding ABMD